Friday, 20 Jul 2018

You are here

The RheumNow Week in Review - 17 November 2017

Dr. Jack Cush reviews the news and highlights from the past week on RheumNow.com. This week he covers FDA warnings on gout drugs, steroid use in Australia, biosimilars lost savings and methotrexate hepatotoxicity in psoriatic arthritis (PsA).

  1. HTN redefined as 130/80!! The American Heart Association estimates the change will mean 46 percent of adults in the USA have HTN https://t.co/zVPZN8JaiX
  2. 3699 RA pts in Australian registry show decreasing pred use from 2001-2015 (55%--39%). Corticosteroid use is  associated with use of DMARDs/NSAID/opioids, higher disease activity, lower pain scores, worse HAQ scores BUT was NOT associated w/ biologic use. https://t.co/UJxn1Wbzi1
  3. IL-17–producing αβ T cell clones with psoriasis-specific antigen receptors exist in clinically resolved psoriatic skin lesions and represent the disease-initiating pathogenic T cells in psoriasis. https://t.co/Lj4B4dQ25N
  4. Abbvies 9/17 settlement with Amgen that allows Amgens adalimumab biosimilar (Amjevita) to begin sales in EU Oct 2018 and in the USA in 2023 is estimated to cost the US Centers of Medicare and Medicaid (CMS) at least US$1.48 billion in savings. … https://t.co/S21dfEjadJ
  5. FDA issues a Safety Alert over FEBUXOSTAT and increased risk of Cardiac Death (compared to allopurinol users). This is based on comparative 6000 pt safety trial wherein Febuxostat showed an increased risk of heart-related deaths and death from all causes. https://t.co/3clsintj7L
  6. Smoking Paradox in PsA -  a UK study shows smoking was positively related to PsA risk in the general population (HR 1.27), but negatively associated with PsA risk among patients with psoriasis (HR 0.91). https://t.co/N7ZEgUYHhH
  7. Metanalysis of 6 studies, 7908 controls and 2899 cases, showed that vitamin C intake was associated with lower risk of hip fracture [OR = 0.73, 95% CI = 0.55-0.97].  A 50 mg/d increase in vitamin C intake statistically reduced by hip Fx risk by 5%  https://t.co/k9qD4YySiX
  8. Pregabalin (not duloxetine) improves pain in hand osteoarthritis in RCT vs PBO - improved pain and function. https://t.co/Hio2wfWLKx
  9. Stroke Increased in Rheumatoid Arthritis  
  10. MTX Doubles Hepatotoxicity Risk in Psoriasis Patients 
  11. Thiopurines and Anti-TNF drugs in IBD Associated with Increased Lymphoma Risk  
Disclosures: 
The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

The RheumNow Week in Review – Cocoon Therapy? (7.20.18)

Dr. Jack Cush reviews highlights from the news and social media on RheumNow.com in the past week. 

Proposed Changes for 2019 Medicare Fee Schedule

On July 12th the Centers for Medicare & Medicaid Services (CMS) released its proposed rule changes for the 2019 Medicare physician fee schedule.  This year, CMS has combined the Medicare physician fee schedule proposed rule with recommendations for the Quality Payment Program (QPP), which will be officially published in the Federal Register on July 27.

Trend Towards Fewer Self-Employed Physicians

 

A nationwide survey study analyzed healthcare provider (HCP) employment type (self-employed, employed by private sector, or employed by government) and annual labor earnings (2001 to 2015) and found that the health care landscape is changing with few self-employed practitioners and more being larger organizations. 

The RheumNow Week in Review –Fateful Outcomes in Rheumatology (7.13.18)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com.  Fateful outcomes in Rheumatology, what happens to Seronegatives, IL-23 fails, MRI progression, Not all inflammatory back pain becomes SpA:

The RheumNow Week in Review – Life Savers for Rheumatologists (6.29.18)

Dr. Jack Cush reviews selected news and journal reports from the past week on RheumNow.com.